Volume 21 Issue 11
Nov.  2023
Turn off MathJax
Article Contents
ZHENG Siqiang, LIU Lin, FAN Shendong, SUN Wenbo, CHEN Bin, HE Qiang. Antimicrobial resistance of common pathogens and their special types in urinary tract infection[J]. Chinese Journal of General Practice, 2023, 21(11): 1852-1855. doi: 10.16766/j.cnki.issn.1674-4152.003241
Citation: ZHENG Siqiang, LIU Lin, FAN Shendong, SUN Wenbo, CHEN Bin, HE Qiang. Antimicrobial resistance of common pathogens and their special types in urinary tract infection[J]. Chinese Journal of General Practice, 2023, 21(11): 1852-1855. doi: 10.16766/j.cnki.issn.1674-4152.003241

Antimicrobial resistance of common pathogens and their special types in urinary tract infection

doi: 10.16766/j.cnki.issn.1674-4152.003241
Funds:

 2022KY1172

  • Received Date: 2022-10-25
    Available Online: 2024-01-13
  •   Objective  To investigate the antimicrobial resistance of common pathogenic bacteria and their special types in urine culture of urinary tract infection (UTI) patients, and to provide reference for clinical workers in the empirical treatment of urinary tract infection.  Methods  The urine culture results and drug resistance were collected from the information system database of Zhejiang Provincial People's Hospital from January 2020 to December 2021, and 3 770 UTI patients were eventually included. The isolated pathogens and their drug susceptibility results were statistically analyzed.  Results  A total of 4 284 non-duplicate strains were isolated in this study. There were 2 746 strains (64.10%) of Gram-negative bacteria, 875 strains (20.42%) of Gram-positive bacteria, 385 strains (8.99%) of fungi and 278 strains (6.49%) of mycoplasma. The top four isolates were Escherichia coli, Klebsiella pneumoniae, Enterococcus faecium and Enterococcus faecalis. Among them, the drug resistance rate of the bacteria producing extended-spectrum β-lactamases and carbapenem resistant bacteria was significantly higher than that of common pathogens. The resistance rate of the former to β-lactam and quinolone antibacterial drugs was significantly higher than that of common pathogens, and it maintained good antibacterial activity against antibiotics and carbapenems with enzyme inhibitors. The latter only showed good sensitivity to tigecycline and amikacin.  Conclusion  The most common pathogen in urinary tract infection is still gram-negative bacteria. Drug-resistant bacteria such as producing extended-spectrum β-lactamases and carbapenem resistant bacteria are more than before. Clinical initial use of antibacterial drugs can refer to the results of this study for empirical treatment, and antibacterial drugs can be changed according to the drug resistance of pathogenic bacteria after the results of urine culture are available.

     

  • loading
  • [1]
    PATEL R, POLAGE C, DIEN B J, et al. Envisioning future urinary tract infection diagnostics[J]. Clin Infect Dis, 2022, 74(7): 1284-1292. doi: 10.1093/cid/ciab749
    [2]
    DEMIR M, KAZANASMAZ H. Uropathogens and antibiotic resistance in the community and hospital-induced urinary tract infected children[J]. J Glob Antimicrob Resist, 2020, 20: 68-73. doi: 10.1016/j.jgar.2019.07.019
    [3]
    石婷婷, 李双庆, 梁利波. 降钙素原在感染中的应用及研究进展[J]. 中华全科医学, 2018, 16(4): 620-625. doi: 10.16766/j.cnki.issn.1674-4152.000172

    SHI T T, LI S Q, LIANG L B. Application and research progress of procalcitonin in infection[J]. Chinese Journal of General Practice, 2018, 16(4): 620-625. doi: 10.16766/j.cnki.issn.1674-4152.000172
    [4]
    毛小强, 陈毓, 金晶. 血清降钙素原在急诊感染患者细菌感染病原学分型中的价值分析[J]. 中华全科医学, 2022, 20(1): 65-67, 75. doi: 10.16766/j.cnki.issn.1674-4152.002278

    MAO X Q, CHEN Y, JIN J. Value analysis of serum procalcitonin in etiological typing of bacterial infection in patients with emergency infection[J]. Chinese Journal of General Practice, 2022, 20(1): 65-67, 75. doi: 10.16766/j.cnki.issn.1674-4152.002278
    [5]
    MAJUMDER M, MAHADI A, AHMED T, et al. Antibiotic resistance pattern of microorganisms causing urinary tract infection: a 10-year comparative analysis in a tertiary care hospital of Bangladesh[J]. Antimicrob Resist Infect Control, 2022, 11(1): 156. doi: 10.1186/s13756-022-01197-6
    [6]
    顾丽娜, 司元国, 马广雁, 等. 疑似尿路感染患者中段尿样本培养的病原菌分布和耐药性分析[J]. 中华医院感染学杂志, 2019, 29(18): 2787-2791.

    GU L N, SI Y G, MA G Y, et al. Analysis of the distribution and drug resistance of pathogenic bacteria cultured from midstream urine samples of patients with suspected urinary tract infection[J]. Chinese Journal of Nosocomiology, 2019, 29(18): 2787-2791.
    [7]
    陈中举, 田磊, 杨为民, 等. 2016~2018年泌尿外科患者尿路感染病原菌分布及耐药性分析[J]. 临床泌尿外科杂志, 2020, 35(2): 103-107, 111.

    CHEN Z J, TIAN L, YANG W M, et al. Analysis of pathogen distribution and drug resistance of urinary tract infection in urology patients from 2016 to 2018[J]. Journal of Clinical Urology, 2020, 35(2): 103-107, 111.
    [8]
    王金英. 2017—2019年某医院尿路感染病原菌分布及耐药性分析[J]. 河南医学研究, 2021, 30(11): 2085-2087. doi: 10.3969/j.issn.1004-437X.2021.11.062

    WANG J Y. Distribution and drug resistance of pathogenic bacteria of urinary tract infection in a hospital from 2017 to 2019[J]. Henan Medical Research, 2021, 30(11): 2085-2087. doi: 10.3969/j.issn.1004-437X.2021.11.062
    [9]
    MUNOZ J, UHLEMANN A, BARASCH J. Innate bacteriostatic mechanisms defend the urinary tract[J]. Annu Rev Physiol, 2022, 84: 533-558. doi: 10.1146/annurev-physiol-052521-121810
    [10]
    解泽强, 陈亮, 张曼. 2016—2017年泌尿系感染病原菌特征分析[J]. 标记免疫分析与临床, 2018, 25(5): 610-615.

    XIE Z Q, CHEN L, ZHANG M. Analysis of pathogenic bacteria characteristics of urinary tract infection from 2016 to 2017[J]. Labeled Immunoassays and Clinical Medicine, 2018, 25(5): 610-615.
    [11]
    张环, 樊璠, 毛彩萍. 2014—2019年浙江地区某肿瘤医院尿路感染病原菌的分布及耐药变迁[J]. 中国抗生素杂志, 2020, 45(10): 1053-1057. doi: 10.3969/j.issn.1001-8689.2020.10.015

    ZHANG H, FAN F, MAO C P. The distribution and drug resistance of pathogenic bacteria in urinary tract infection in a tumor hospital in Zhejiang from 2014 to 2019[J]. Chinese Journal of Antibiotics, 2020, 45(10): 1053-1057. doi: 10.3969/j.issn.1001-8689.2020.10.015
    [12]
    DANIEL M, KELLER S, MOZAFARIHASHJIN M, et al. An implementation guide to reducing overtreatment of asymptomatic bacteriuria[J]. JAMA Intern Med, 2018, 178(2): 271-276. doi: 10.1001/jamainternmed.2017.7290
    [13]
    邢桂生. 泌尿外科住院患者泌尿系感染临床及病原菌调查[J]. 中国卫生检验杂志, 2019, 29(19): 2427-2430.

    XING G S. Clinical and pathogenic investigation of urinary tract infection in hospitalized patients in urology[J]. Chinese Journal of Health Laboratory Technology, 2019, 29(19): 2427-2430.
    [14]
    JEAN S, HARNOD D, HSUEH P. Global threat of carbapenem-resistant Gram-negative bacteria[J]. Front Cell Infect Microbiol, 2022, 12: 823684. DOI: 10.3389/fcimb.2022.823684.
    [15]
    ZHANG R, DONG N, HUANG Y, et al. Evolution of tigecycline- and colistin-resistant CRKP (carbapenem-resistant Klebsiella pneumoniae) in vivo and its persistence in the GI tract[J]. Emerg Microbes Infect, 2018, 7(1): 127.
    [16]
    龙姗姗, 喻华, 黄湘宁, 等. 2015—2018年四川省细菌耐药监测网尿液标本细菌分布及耐药性分析[J]. 中华医院感染学杂志, 2020, 30(7): 1066-1071.

    LONG S S, YU H, HUANG X N, et al. Analysis of bacterial distribution and drug resistance in urine specimens of Sichuan Provincial Bacterial Resistance Monitoring Network from 2015 to 2018[J]. Chinese Journal of Nosocomiology, 2020, 30(7): 1066-1071.
    [17]
    杨书才, 唐景云, 周杰, 等. 6 493例泌尿生殖道感染患者解脲支原体和人型支原体感染情况及药敏试验分析[J]. 检验医学与临床, 2019, 16(13): 1888-1891. doi: 10.3969/j.issn.1672-9455.2019.13.028

    YANG S C, TANG J Y, ZHOU J, et al. Analysis of Ureaplasma urealyticum and Mycoplasma hominis infection and drug sensitivity test in 6 493 patients with urogenital tract infection[J]. Laboratory Medicine and Clinic, 2019, 16(13): 1888-1891. doi: 10.3969/j.issn.1672-9455.2019.13.028
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(4)

    Article Metrics

    Article views (232) PDF downloads(22) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return